CVS Health expands affordable access to FDA-approved GLP-1 weight loss therapies via app and MinuteClinic.

CVS Health has revamped its weight management program to improve access to FDA-approved GLP-1 medications, including Zepbound, Foundayo, and Wegovy, through both insurance and cash-pay options. The program features a $29 online MinuteClinic visit with licensed clinicians available 24/7, same-day medication pickup at 9,000 CVS Pharmacy locations, and personalized pharmacist support. A new collaboration with Eli Lilly allows eligible patients to view transparent pricing and access multiple payment options via the CVS Health app. This integrated approach aims to simplify treatment navigation, reduce costs, and support ongoing care for adults managing weight, with no membership or recurring fees required.